Rubicon Research Limited
Motilal Oswal Mutual Fund increased its stake in Rubicon Research Limited from 1.56% to 1.73%, acquiring 287,535 shares. The value of the additional shares is ₹43.15 crore, based on Rubicon Research's share price of ₹1500.80.
A pharmaceutical company engaged in the development, manufacturing, and commercialization of differentiated drug formulations across multiple therapeutic areas. Incorporated in 1999, the company specializes in creating specialized formulations that address specific medical needs in the Indian healthcare market. Its integrated operations span research and development, manufacturing of quality pharmaceuticals, and distribution. The company distinguishes itself through its focus on bringing innovative, differentiated solutions to patients and healthcare providers.
AMC arm of Motilal Oswal Financial Services, founded on the belief in long-term buy-and-hold quality investing. Manages over Rs 1.5 lakh crore. Famous for the QGLP (Quality, Growth, Longevity, Price) investment framework and concentrated portfolios with very low churn. Flagship Motilal Oswal Midcap and Motilal Oswal Flexi Cap funds reflect deep conviction positioning with 15-25 stock portfolios.